| Model Number |
HARMONY-25 |
| Medical Device Problem Codes |
No Apparent Adverse Event (3189); Patient Device Interaction Problem (4001)
|
| Health Effect - Clinical Codes |
Tachycardia (2095); No Clinical Signs, Symptoms or Conditions (4582)
|
| Date of Event |
05/28/2025
|
|
Type of Reportable Event
|
Serious Injury
|
|
Event or Problem Description
|
|
It was reported that following the implant of the transcatheter bioprosthetic pulmonary valve, during the first postoperative night, runs of non-sustained ventricular tachycardia (nsvt) were observed.Treatment was not reported.However, hospitalization was required.Approximately 2 months following implant the nsvt was resolved.The physician indicated the nsvt was causally related to the delivery catheter system (dcs), valve, and implant procedure.
|
| |
|
Additional Manufacturer Narrative
|
|
Section d references the main component of the system.Other medical products in use during the event include: brand name harmony delivery catheter system; product id: harmony-dcs (lot: 0012663878); product type: 0195-heart valves; implant date na ; explant date na.Medtronic submits this report to comply with fda regulations 21 cfr parts 4 and 803.Medtronic has made reasonable efforts to provide as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.Medtronic will submit a supplemental report if additional relevant information becomes known.
|
| |
|
Additional Manufacturer Narrative
|
|
Additional information received showed there is no information to reasonably suggest the device in this report may have caused or co ntributed to a death or serious injury or malfunctioned.Therefore, this event does not meet the reporting requirements in 21 cfr 803.Updated data: b5.A second paragraph was added.B7.Relevant history was added.D10.The initial medwatch was submitted listing the dcs as a concomitant device to the reported event.H6.And additional codes.Were changed.Medtronic submits this report to comply with fda regulations 21 cfr parts 4 and 803.Medtronic has made reasonable efforts to provide as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.Medtronic will submit a supplemental report if additional relevant information becomes known.
|
| |
|
Event or Problem Description
|
|
It was reported that following the implant of the transcatheter bioprosthetic pulmonary valve, during the first postoperative night, runs of non-sustained ventricular tachycardia (nsvt) were observed.Treatment was not reported.However, hospitalization was required.Approximately 2 months following implant the nsvt was resolved.The physician indicated the nsvt was causally related to the delivery catheter system (dcs), valve, and implant procedure.Additional information was received to report the patient's baseline medical history included pre-existing nsvt.The patient was not prescribed medication to treat the pre-existing nsvt; however, a beta-blocker (metoprolol) medication was initiated during admission as first-line treatment.The previously documented narrative was corrected to report the patient's hospitalization was not prolonged as a result of the observed nsvt.
|
| |
|
Search Alerts/Recalls
|